To learn more about YORK’S COVID-19 response, visit our Coronavirus Updates page.

Skip to Main Content

2019-2020 Pharmaceutical Science and Business (MS) Assessment Plan

Assessment Year: 2019-2020
School: Arts and Sciences
Department: Chemistry
Program: Pharmaceutical Science and Business (MS)
Department Chair: echang
Department Assessment Coordinator: cfoster
Program Coordinator: dmusumeci
Completed by: dmusumeci
Other Contributors:
Date Completed:2019/11/14 14:36:00 US/Eastern

Program Mission

The goal of the Masters in Pharmaceutical Science and Business program at York College is to prepare students for responsible positions in the pharmaceutical and biotechnology industry management. Opportunities for students, upon successfully completing the program, include careers with Biotechnology and Pharmaceutical companies, professional societies, and government/international agencies.

Assessment Plan

Outcome 1

Program Goal

Students will obtain advanced knowledge of the regulations involved in the preparation, marketing, and post marketing surveillance of pharmaceutical products.

Program Student Learning Outcome

Outcome 2.1 Students will describe the regulatory aspects involved in the preparation of pharmaceutical products, the design of clinical trials, and the submission of regulatory applications.

Alignment with York’s Institutional Learning Outcomes (ILOs)

Intellectual Discovery and Creativity - Demonstrate excellence in academic inquiry, creativity, research, collaboration and professional growth.

Alignment with MSCHE Standard III Competencies

Scientific and Quantitative Reasoning

From which course(s), section(s) will you collect student artifacts?

PHS 505 PHS 513

Sample Size

PHS 505: 10 PHS 513: 3

Measure

In-class exams

Measure Type

Direct

Target

70% from the class exams


Outcome 2

Program Goal

Students will obtain advanced knowledge of the regulations involved in the preparation, marketing, and post marketing surveillance of pharmaceutical products.

Program Student Learning Outcome

Outcome 2.2 Students will become familiar with the U.S. laws regulating pharmaceuticals, application processes for clinical development, and marketing of new drugs.

Alignment with York’s Institutional Learning Outcomes (ILOs)

Intellectual Discovery and Creativity - Demonstrate excellence in academic inquiry, creativity, research, collaboration and professional growth.

Alignment with MSCHE Standard III Competencies

Scientific and Quantitative Reasoning

From which course(s), section(s) will you collect student artifacts?

PHS 505 PHS 513

Sample Size

PHS 505: 10 PHS 513: 3

Measure

In-class exams

Measure Type

Direct

Target

70% from the class exams


Outcome 3

Program Goal

Students will obtain advanced knowledge of the regulations involved in the preparation, marketing, and post marketing surveillance of pharmaceutical products.

Program Student Learning Outcome

Outcome 2.3 Students will explain advanced knowledge of project and product managements and pharmaceutical marketing.

Alignment with York’s Institutional Learning Outcomes (ILOs)

Intellectual Discovery and Creativity - Demonstrate excellence in academic inquiry, creativity, research, collaboration and professional growth.

Alignment with MSCHE Standard III Competencies

Scientific and Quantitative Reasoning

From which course(s), section(s) will you collect student artifacts?

PHS 506 PHS 507

Sample Size

9

Measure

In-class exams

Measure Type

Direct

Target

70% from the class exams


Outcome 4

Program Goal

Students will obtain advanced knowledge of the regulations involved in the preparation, marketing, and post marketing surveillance of pharmaceutical products.

Program Student Learning Outcome

Outcome 2.4 Students will illustrate the ethical principles faced by the pharmaceutical industry and recognize the restrictions on animal and human subject research.

Alignment with York’s Institutional Learning Outcomes (ILOs)

Intellectual Discovery and Creativity - Demonstrate excellence in academic inquiry, creativity, research, collaboration and professional growth.

Alignment with MSCHE Standard III Competencies

Scientific and Quantitative Reasoning

From which course(s), section(s) will you collect student artifacts?

PHS 506 PHS 507

Sample Size

9

Measure

In-class exams

Measure Type

Direct

Target

70% from the class exams


Rationale for the Plan

Last year, the Pharmaceutical Science MS assessed Goal 3, Students will acquire advanced knowledge of pharmacokinetic/pharmacodynamic principles and pharmacogenomics. This year, the Pharmaceutical Science MS program will to assess students’ advanced knowledge of the regulations involved in the preparation, marketing, and post marketing surveillance of pharmaceutical products (Goal 2). Therefore, the program committee members chose Foundations of Regulatory Afffairs (PHS 505), Pharmaceutical Ethics and Intellectual Property Management (PHS 506), and Pharmaceutical Industry and Business (PHS 507), and Design of Clinical Trials (PHS 513) to collect the data. The assessment will be completed through class examinations for direct measurement.

Data Collection and Evaluation

The schedule for the exams varies for each class; most likely, the class exams will be given at the end of October and the end of March. Daniele Musumeci, Zhu Zhou, Deb Chakravarti, and Bulbul Chakravarti will participate in the assessment.

Identify the assessment tool (provide rubrics as appropriate) [Open-ended Problem Rubric] -Exemplary/Mastery (5-4.5): After careful analysis of the question, requested and relevant concepts are completely found and applied in an appropriate way with sound strategies. Necessary figures are utilized to support the answer. -Acceptable/Developing (4.4-3.5): The answer generally shows a good demonstration for the question, but with mistakes. -Poor/Approaching (3.4-3): A portion of the answer is relevant but is not specific enough to properly address the chemical aspect requested in the question. -Attempted/Emerging (2.9-0): Mostly an irrelevant answer

-This assessment will give the program an indication of whether the student is receiving the required education at the appropriate level; it will also provide data to assess whether the student is prepared for the next level of the sequential classes in the curriculum map. Then, the Pharmaceutical Science Program will be able to develop those class curricula with a stronger conceptual linkage.